Ekso Bionics to Present at the H.C. Wainwright Global Investment Conference
May 17 2022 - 4:05PM
Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in
exoskeleton technology for medical and industrial use, today
announced that management will present at the H.C. Wainwright
Global Investment Conference taking place May 23-26, 2022.
The pre-recorded presentation will be
available to view on-demand as of 4:00 AM PT / 7:00 AM ET, Tuesday,
May 24, 2022 throughout the entirety of the conference and on the
investor section of the Company’s website
at www.eksobionics.com.
About Ekso
Bionics® Ekso Bionics® is a leading
developer of exoskeleton solutions that amplify human potential by
supporting or enhancing strength, endurance, and mobility across
medical and industrial applications. Founded in 2005, the Company
continues to build upon its industry-leading expertise to design
some of the most cutting-edge, innovative wearable robots available
on the market. Ekso Bionics is the only exoskeleton company to
offer technologies that range from helping those with paralysis to
stand up and walk, to enhancing human capabilities on job sites
across the globe. Ekso Bionics is headquartered in the San
Francisco Bay Area and is listed on the Nasdaq Capital Market under
the symbol “EKSO.” For more information, visit: www.eksobionics.com
or follow @EksoBionics on Twitter.
Investor Contact:David
Carey212-867-1768investors@eksobionics.com
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Apr 2023 to Apr 2024